This is a comprehensive, textbook-level overview of diarrhoea compiled from multiple authoritative sources. Here is a brief orientation to the sections covered:
What Was Covered
1. Definition
WHO definition (≥3 loose stools/day), quantitative threshold (>200 g/day), and the critical physiological context - 9 L of fluid enters the gut daily, yet only 100-150 mL is excreted normally.
2. Types (Classification)
- By duration: Acute (<14 days), Persistent (14-28 days), Chronic (>4 weeks)
- By mechanism: Secretory, Osmotic, Inflammatory/Exudative, Malabsorptive/Fatty, Motility-related, Psychogenic
- By stool character: Watery, Bloody (dysentery), Fatty (steatorrhoea) - each pointing to different aetiologies
3. Etiology
Full breakdown across viral (rotavirus, norovirus), bacterial (cholera, Shigella, Salmonella, C. difficile, STEC), protozoal (Giardia, Entamoeba, Cryptosporidium), and non-infectious causes (IBD, drugs, malabsorption, endocrine, surgical, functional), including special populations (AIDS, travellers, diabetics, hospitalised patients).
4. Pathophysiology
Detailed mechanisms: enterotoxin-mediated hypersecretion (cAMP/cGMP pathway), mucosal invasion and inflammation, osmotic mechanism (virus-damaged microvilli + bacterial fermentation), and motility disturbances.
5. Clinical Features
General symptoms, dehydration severity grading table, and stool characteristics as diagnostic clues (rice-water stools, dysentery, steatorrhoea, nocturnal diarrhoea).
6. Diagnostic Criteria
Full algorithmic approach - history, physical examination, laboratory tests (fecal osmotic gap formula, fecal leukocytes, stool culture, O&P, endocrine screens), imaging, and a decision algorithm for acute vs. chronic diarrhoea.
7. Management
- Rehydration: ORS composition and physiological rationale (Na-glucose co-transport), IV fluids for severe cases
- Antimotility agents: Loperamide, diphenoxylate, bismuth, octreotide, cholestyramine
- Antibiotics: Pathogen-specific table with drug choices and important caveats (avoid in STEC)
- Specific conditions: C. difficile (vancomycin/fidaxomicin/FMT), IBD, microscopic colitis, VIPoma
- Adjuncts: Zinc supplementation (WHO-recommended for children), probiotics (recent 2024 meta-analysis support)
- Hospitalisation criteria: Red flag indicators